Live
ePaper
Search
Home > India > UPDATE 1-US FDA declines to approve Capricor's cell therapy for Duchenne muscular dystrophy; shares slump

UPDATE 1-US FDA declines to approve Capricor's cell therapy for Duchenne muscular dystrophy; shares slump

Written By:
Last Updated: November 21, 2026 05:16:49 IST

(Adds shares in paragraph 2, details throughout) Nov 20 (Reuters) – The US Food and Drug Administration declined to approve Capricor Therapeutics' experimental cell therapy for a fatal inherited

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?